US Measles Resurgence Exposes Decades of Eroded Vaccination Infrastructure and Global Equity Gaps
Original framing: “Pennsylvania issues alert on congenital measles—something US hasn't seen for decades” — Ars Technica
The trickster Hermes — patron of boundaries and crossroads — laughs at Pennsylvania's 'alert' on congenital measles: a state that spends $400M annually on prison healthcare but $0 on pre-conception MMR verification for Medicaid recipients. Erasmus's 'Praise of Folly' would note the irony that the US eliminated measles in 2000 using Soviet-era vaccine diplomacy (the Khasanovich strain), then dismantled the very public health infrastructure that made it possible. Anansi the spider would weave this tale: the pharmaceutical industry funds anti-vaccine misinformation through 'patient advocacy' front groups while lobbying against the TRIPS waiver that would let Global South nations produce MMR — ensuring the virus returns to haunt the wealthy. The congenital case is not a medical failure but the trickster's invoice for stolen equity.
The Pennsylvania congenital measles alert is not a medical surprise but a structural invoice: the US dismantled the Vaccines for Children infrastructure that ended the 1991 resurgence, replaced school mandates with exemption loopholes lobbied for by anti-vaccine networks, and blocked global MMR access through WTO patent enforcement — ensuring the virus would return to the most vulnerable.
The Navajo Nation's 95% coverage and Cuba's zero congenital cases since 1993 prove elimination is a governance choice, not a biomedical limit. Restoring pre-conception immunity verification, deploying kinship-based community health workers, constitutionally constraining exemption expansion, and funding global vaccine equity are not separate solutions but a single systemic repair. Until the US treats vaccination as collective infrastructure — not individual choice — congenital measles will remain the trickster's recurring lesson in the cost of stolen equity.